Position in RCUS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,754,805
-$1,134,368 QoQ
Shares Held
81,241
-33.0% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Knott David M Jr holds $72,324,865 across 34 Biotechnology names. RCUS ranks #13 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SNDX |
Syndax Pharmaceuticals Inc
|
422,000 | $9,857,920 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
90,000 | $6,683,400 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
63,000 | $6,640,200 | |
| 4 | IOVA |
Iovance Biotherapeutics, Inc.
|
1,600,000 | $5,616,000 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
140,633 | $4,178,206 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
104,000 | $4,002,960 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
181,000 | $3,540,360 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
93,058 | $3,148,152 |
All Filings in RCUS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,754,805 | 81,241 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,889,173 | 121,241 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,294,720 | 95,200 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $569,800 | 70,000 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $94,200 | 12,000 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||